Cited by 76Gastrointestinal motility and disordersGenetic Associations and EpidemiologyGut microbiota and health

Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome

Open access
Bonfiglio, Ferdinando, Zheng, Tenghao, Garcia-Etxebarria, Koldo, Hadizadeh, Fatemeh, Bujanda, Luis, Bresso, Francesca, Agreus, Lars, Andreasson, Anna +28 more·2018·Gastroenterology

Abstract

Background & aims Genetic factors are believed to affect risk for irritable bowel syndrome (IBS), but there have been no sufficiently powered and adequately sized studies. To identify DNA variants associated with IBS risk, we performed a genome-wide association study (GWAS) of the large UK Biobank population-based cohort, which includes genotype and health data from 500,000 participants. Methods We studied 7,287,191 high-quality single nucleotide polymorphisms in individuals who self-reported a doctor's diagnosis of IBS (cases; n = 9576) compared to the remainder of the cohort (controls; n = 336,499) (mean age of study subjects, 40-69 years). Genome-wide significant findings were further investigated in 2045 patients with IBS from tertiary centers and 7955 population controls from Europe and the United States, and a small general population sample from Sweden (n = 249). Functional annotation of GWAS results was carried out by integrating data from multiple biorepositories to obtain biological insights from the observed associations. Results We identified a genome-wide significant association on chromosome 9q31.2 (single nucleotide polymorphism rs10512344; P = 3.57 × 10-8) in a region previously linked to age at menarche, and 13 additional loci of suggestive significance (P < 5.0×10-6). Sex-stratified analyses revealed that the variants at 9q31.2 affect risk of IBS in women only (P = 4.29 × 10-10 in UK Biobank) and also associate with constipation-predominant IBS in women (P = .015 in the tertiary cohort) and harder stools in women (P = .0012 in the population-based sample). Functional annotation of the 9q31.2 locus identified 8 candidate genes, including the elongator complex protein 1 gene (ELP1 or IKBKAP), which is mutated in patients with familial dysautonomia. Conclusions In a sufficiently powered GWAS of IBS, we associated variants at the locus 9q31.2 with risk of IBS in women. This observation may provide additional rationale for investigating the role of sex hormones and autonomic dysfunction in IBS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2018.03.064

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The biopsychosocial model conceptualises a genetic predisposition, where adverse events in early life, psychological factors, or gastrointestinal infections then trigger alterations in the enteric nervous system, which controls gastrointestinal motor, sensory, mucosal barrier, and secretory responses.

    “The biopsychosocial model to explain symptoms of abdominal pain and disordered bowel habit in IBS conceptualised a genetic predisposition, where adverse events in early life, psychological factors, or gastrointestinal infections then trigger alterations in the enteric nervous system, which controls gastrointestinal motor, sensory, mucosal barrier, and secretory responses (Figure 3). 21”

    From Irritable bowel syndrome (2020) · cites this paper as [21]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 44

  1. [3]Enck P Aziz Q Barbara G Irritable bowel syndrome Nat Rev Dis Prim 2016 2 1 24 PMC5001845 27159638
  2. [4]Saito YA The Role of Genetics in IBS Gastroenterol Clin North Am 2011 40 45 67 21333900 PMC3056499
  3. [5]Waehrens R Ohlsson H Sundquist J Risk of irritable bowel syndrome in first-degree, second-degree and third-degree relatives of affected individuals: a nationwide family study in Sweden Gut 2015 64 215 221 24694578
  4. [6]Beyder A Mazzone A Strege PR Loss-of-function of the voltage-gated sodium channel NaV1.5 (Channelopathies) in patients with irritable bowel syndrome Gastroenterology 2014 146 1659 1668 24613995 PMC4096335
  5. [7]Henström M Diekmann L Bonfiglio F Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome Gut 2016 gutjnl-2016-312456 PMC5563477 27872184
  6. [8]Zucchelli M Camilleri M Andreasson AN Association of TNFSF15 polymorphism with irritable bowel syndrome Gut 2011 60 1671 1677 21636646 PMC3922294
  7. [9]Henström M Hadizadeh F Beyder A TRPM8 polymorphisms associated with increased risk of IBS-C and IBS-M Gut 2017 66 1725 1727 27974553 PMC5561393
  8. [10]Wouters MM Lambrechts D Knapp M Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome Gut 2014 63 1103 11 24041540
  9. [11]Henström M Zucchelli M Söderhäll C NPSR1 polymorphisms influence recurrent abdominal pain in children: A population-based study Neurogastroenterol Motil 2014 26 1417 1425 25091462
  10. [12]Ek WE Reznichenko A Ripke S Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts Gut 2015 64 1774 1782 25248455
  11. [13]Camilleri M Carlson P Zinsmeister AR Neuropeptide S Receptor Induces Neuropeptide Expression and Associates With Intermediate Phenotypes of Functional Gastrointestinal Disorders Gastroenterology 2010 138 98 107.e4 19732772 PMC2813358
  12. [14]D’Amato M Genes and functional GI disorders: from casual to causal relationship Neurogastroenterol Motil 2013 25 638 649 23826979
  13. [15]Bycroft C Freeman C Petkova D Genome-wide genetic data on ~500,000 UK Biobank participants bioRxiv 2017 166298
  14. [16]Lichtenstein P Sullivan PF Cnattingius S The Swedish Twin Registry in the third millennium: an update Twin Res Hum Genet 2006 9 875 82 17254424
  15. [17]Franke A McGovern DPB Barrett JC Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci Nat Genet 2010 42 1118 1125 21102463 PMC3299551
  16. [18]Meschia JF Arnett DK Ay H Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes Stroke 2013 44 2694 702 24021684 PMC4056331
  17. [20]Sonnega A Faul JD Ofstedal MB Cohort Profile: the Health and Retirement Study (HRS) Int J Epidemiol 2014 43 576 585 24671021 PMC3997380
  18. [21]Mujagic Z Tigchelaar EF Zhernakova A A novel biomarker panel for irritable bowel syndrome and the application in the general population Sci Rep 2016 6 26420 27263852 PMC4893613
  19. [22]Li Y Oosting M Smeekens SP A Functional Genomics Approach to Understand Variation in Cytokine Production in Humans Cell 2016 167 1099 1110.e14 27814507
  20. [23]Walter SA Kjellström L Nyhlin H Assessment of normal bowel habits in the general adult population: the Popcol study Scand J Gastroenterol 2010 45 556 566 20205503
  21. [24]Watanabe K Taskesen E Van Bochoven A Functional mapping and annotation of genetic associations with FUMA Nat Commun 2017 8 1826 29184056 PMC5705698
  22. [25]Day FR Thompson DJ Helgason H Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk Nat Genet 2017 49 834 841 28436984 PMC5841952
  23. [27]Elks CE Perry JRB Sulem P Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies Nat Genet 2010 42 1077 85 21102462 PMC3140055
  24. [28]Martínez C Rodiño-Janeiro BK Lobo B miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea Gut 2017 66 1537 1538 PMC5561373 28082316
  25. [29]Beyder A Farrugia G Ion channelopathies in functional GI disorders Am J Physiol Gastrointest Liver Physiol 2016 311 G581 G586 27514480 PMC5142191
  26. [30]Strege PR Mazzone A Bernard CE Irritable bowel syndrome (IBS) patients have SCN5A channelopathies that lead to decreased Na V 1.5 current and mechanosensitivity Am J Physiol Liver Physiol 2017 ajpgi.00016.201 PMC5966747 29167113
  27. [31]Jankipersadsing SA Hadizadeh F Bonder MJ A GWAS meta-analysis suggests roles for xenobiotic metabolism and ion channel activity in the biology of stool frequency Gut 2017 66 756 758 27473416 PMC5529970
  28. [33]Day FR Elks CE Murray A Puberty timing associated with diabetes, cardiovascular disease and also diverse health outcomes in men and women: The UK Biobank study Sci Rep 2015 5 1 12 PMC4471670 26084728
  29. [34]Heitkemper M Jarrett M Bond EF Impact of sex and gender on irritable bowel syndrome Biol Res Nurs 2003 5 56 65 12886671
  30. [35]Viramontes BE Camilleri M McKinzie S Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome Am J Gastroenterol 2001 96 2671 2676 11569693
  31. [37]Lovell RM Ford AC Effect of Gender on Prevalence of Irritable Bowel Syndrome in the Community: Systematic Review and Meta-Analysis Am J Gastroenterol 2012 107 991 1000 22613905
  32. [38]Houghton LA Heitkemper M Crowell MD Age, gender, and women’s health and the patient Gastroenterology 2016 150 1332 1343e4 27144622
  33. [39]Heitkemper MM Chang L Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gend Med 2009 6 152 167 19406367 PMC3322543
  34. [40]Hogan AM Collins D Baird AW Estrogen and its role in gastrointestinal health and disease Int J Colorectal Dis 2009 24 1367 1375 19655153
  35. [41]Taché Y Bonaz B Corticotropin-releasing factor receptors and stress-related alterations of gut motor function J Clin Invest 2007 117 33 40 17200704 PMC1716215
  36. [42]Longstreth GF Thompson WG Chey WD Functional Bowel Disorders Gastroenterology 2006 130 1480 1491 16678561
  37. [44]Meleine M Matricon J Gender-related differences in irritable bowel syndrome: Potential mechanisms of sex hormones World J Gastroenterol 2014 20 6725 6743 24944465 PMC4051914
  38. [46]Houghton LA Lea R Jackson N The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers Gut 2002 50 471 474 11889064 PMC1773170
  39. [47]Kojic M Wainwright B The Many Faces of Elongator in Neurodevelopment and Disease Front Mol Neurosci 2016 9 115 27847465 PMC5088202
  40. [48]Le Dily F Beato M Signaling by steroid hormones in the 3D nuclear space Int J Mol Sci 2018 19 306 PMC5855546 29360755
  41. [49]Norcliffe-Kaufmann L Slaugenhaupt SA Kaufmann H Familial dysautonomia: History, genotype, phenotype and translational research Prog Neurobiol 2017 152 131 148 27317387
  42. [50]Maayan C Sela O Axelrod F Gynecological aspects of female familial dysautonomia Isr Med Assoc J 2000 2 679 683 11062768
  43. [51]Camilleri M McKinzie S Busciglio I Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel Syndrome Clin Gastroenterol Hepatol 2008 6 772 81 18456567 PMC2495078
  44. [52]Cheng P Shih W Alberto M Autonomic response to a visceral stressor is dysregulated in irritable bowel syndrome and correlates with duration of disease Neurogastroenterol Motil 2013 25 e650 659 23822743 PMC3788031

Cited by

Sorted by citations

Authors
Bonfiglio, F., Zheng, T., Garcia-Etxebarria, K., Hadizadeh, F., Bujanda, L., Bresso, F., Agreus, L., Andreasson, A., Dlugosz, A., Lindberg, G., Schmidt, P. T., Karling, P., Ohlsson, B., Simren, M., Walter, S., Nardone, G., Cuomo, R., Usai-Satta, P., Galeazzi, F., Neri, M., Portincasa, P., Bellini, M., Barbara, G., Latiano, A., Hübenthal, M., Thijs, V., Netea, M. G., Jonkers, D., Chang, L., Mayer, E. A., Wouters, M. M., Boeckxstaens, G., Camilleri, M., Franke, A., Zhernakova, A., & D’Amato, M.
Affiliations
  • Karolinska Institutet (SE)
  • Karolinska University Hospital (SE)
  • Umeå University (SE)
  • Lund University (SE)
  • Linköping University (SE)
  • Federico II University Hospital (IT)
  • University of Padua (IT)
  • University of Chieti-Pescara (IT)
  • University of Bari Aldo Moro (IT)
  • University of Pisa (IT)
  • IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
  • Casa Sollievo della Sofferenza (IT)
  • Christian-Albrechts-Universität zu Kiel (DE)
  • Florey Institute of Neuroscience and Mental Health (AU)
  • University of Bonn (DE)
  • Maastricht University Medical Centre (NL)
  • University of California, Los Angeles (US)
  • KU Leuven (BE)
  • Mayo Clinic (US)
  • University Medical Center Groningen (NL)
  • Ikerbasque (ES)
Corresponding author
D’Amato, Mauro
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2018-07
Volume
155
Issue
1
Pages
168-179
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2796338032
Cited by
76
References
7
Citations by year
2026: 3 · 2025: 11 · 2024: 8 · 2023: 12 · 2022: 10 · 2021: 11 · 2020: 11 · 2019: 9 · 2018: 1
FWCI
7.35
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (acceptedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Lirias (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Funders
  • University of Essex
  • Wellcome Trust (EU-FP7-)
  • Understanding Society
  • Eusko Jaurlaritza (2015111133)
  • Ministerio de Economía y Competitividad (FIS PI17/00308)
  • Vetenskapsrådet (2017-02403, 2013-03862)
  • National Institutes of Health (41301, P30 DK, DK64539)
  • Medical Research Council (MC_PC_17228)
  • Economic and Social Research Council
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK048351, P50DK064539, P30DK041301)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
irritable bowel syndrome, sex differences, women, irritable bowel syndrome with constipation, hard stools, age at menarche, ELP1, IKBKAP, familial dysautonomia, sex hormones, autonomic dysfunction, genetic risk variants
MeSH terms
Adult, Aged, Chromosomes, Human, Pair 9, Constipation, Europe, Female, Genotype, Humans, Male, Menarche, Middle Aged, Sex Factors, Sweden, United States, Genetic Variation, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Irritable Bowel Syndrome, Genome-Wide Association Study, Self Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review